Dose for CT examination of children can be calculated by the children’s weight rather than torso diameter measurement.
Dose estimation for children undergoing CT examinations may be based on body weight instead of body diameter, according to a study published in the American Journal of Roentgenology.
Researchers from Harvard Medical School sought to determine if size-specific dose estimates (SSDEs) needed for children undergoing CT examinations, which require manual measurement of torso diameters, could be replaced by using individual body weights.
The study involved 483 children who had undergone 522 CT examinations (187 of the chest and 335 of the abdomen-pelvis). The SSDEs were anteroposterior (DAP), lateral (DLAT) and effective (DE). The children ranged in age from 6 to 20 years.
The effective diameter (DE1) was calculated as the square root of the product of DAP and DLAT. A second measurement of effective diameter (DE2) was obtained using automated software.
Results showed that the median body weight was 51 kg.
The researchers found that the SSDE measured using body weight was not statistically different than SSDE measured using effective diameters. “Children weighing less than 27 kg and between 46 and 100 kg had statistically significant correlations with torso diameters, whereas only anteroposterior and effective diameters were correlated with children weighing between 27 and 45 kg,” the authors wrote. “Children less than 4 years old had strong correlation with all diameters. Adolescents (15–18 years) did not have statistically significant correlation with any of the diameters.”
The researchers concluded that clinicians could use the simpler method of calculating size-specific dose based on the body weight of children who are undergoing CT examination.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.